Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Funding for CTSA Program hubs to advance clinical translation, partnerships, research, and training for faster, more inclusive medical advancements.
Browse similar grants
Funder: National Institutes of Health
Due Dates: January 28, 2027 (Application) | May 28, 2027 (Application) | September 28, 2027 (Application)
Funding Amounts: Maximum project period: 7 years; published 2026 budget tiers allow $2.6 million–$6.5 million annually in direct costs
Summary: Supports CTSA hubs advancing generalizable clinical and translational science through research, shared resources, workforce development, and collaboration.
Key Information: Initial UM1 submissions require a concurrent K12 companion application and an accredited graduate school within the applicant or partnership.
Description
The Clinical and Translational Science Award (CTSA) Program, administered by NIH’s National Center for Advancing Translational Sciences (NCATS), supports hubs within a national collaborative consortium. Hubs develop, demonstrate, and disseminate scientific and operational innovations that accelerate translation from early discoveries and first-in-human studies to medical practice and community health. The focus is translational science: generalizable solutions to research bottlenecks, rather than basic discovery or work addressing only a particular disease.
Supported activities include clinical research methods, data science and informatics, research resources and pilots, community and stakeholder engagement, and training for clinical research professionals. Hubs are expected to collaborate locally, regionally, and nationally, improve clinical research quality and efficiency, address health disparities, and provide capacity to respond rapidly to urgent public health needs.
